Anidulafungin—challenges in development and validation of an LC-MS/MS bioanalytical method validated for regulated clinical studies

Development of an HPLC Method for the Determination of Anidulafungin in Human Plasma and Saline

(2011) C. A. Sutherland et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification?

(2011) Jens Martens-Lobenhoffer et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Quantitation of Azoles and Echinocandins in Compartments of Peripheral Blood by Liquid Chromatography-Tandem Mass Spectrometry

(2010) F. Farowski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole-N-Oxide, Anidulafungin, and Caspofungin

(2010) L. A. Decosterd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations

(2009) Douglas M. Fast et al.   AAPS Journal

Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults

(2009) J. L. Crandon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro and In Vivo Studies To Characterize the Clearance Mechanism and Potential Cytochrome P450 Interactions of Anidulafungin

(2008) B. D. Damle et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Commercialization and Late-Stage Development of a Semisynthetic Antifungal API: Anidulafungin/d-Fructose (Eraxis)

(2008) Timothy Norris et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT